What physicians need to know about the expanded carotid artery stenting coverage, including choice of therapy, shared ...
Over the years, TF-CAS saw reduced adoption due to lack of reimbursement in many patients, as well as concerns by some ...
Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas ASCO Guidelines ...
McMaster researchers found that deep abdominal and liver fat can quietly damage arteries, even in people who appear fit.